American Bio Medica Corporation
American Bio Medica Corporation (ABMC) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0000896747 · ABMC · OTC · as of Jun 9, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0000896747 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
American Bio Medica Corporation (OTC: ABMC) has submitted 602 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1997. As a Healthcare sector company with CIK 0000896747, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is American Bio Medica Corporation's most comprehensive regulatory disclosure. The most recent American Bio Medica Corporation 10-K was filed on 2023-03-21 for fiscal year ending 2023. Historical ABMC 10-K annual reports are available from 1996 through 2023.
Investors researching American Bio Medica Corporation SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
ABMC SEC Filings · 8 questionsAmerican Bio Medica Corporation (ABMC) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 602 filings and access original documents at no cost. American Bio Medica Corporation's CIK is 0000896747.